Diatrizoate Meglumine and Diatrizoate Sodium
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
31722-019 -
Package NDC
31722-019-31 -
Package NDC
31722-019-32 -
Application number
ANDA215049 -
SPL ID
2e7917f2-e573-cccb-e063-6294a90a203c -
SPL set ID
a216a7d5-3c28-482b-956a-93ae146e3763 -
UNII
3X9MR4N98U -
UNII
V5403H8VG7
What the source publishes
- Labeler
- Camber Pharmaceuticals, Inc.
- Active ingredients
- Diatrizoate Meglumine and Diatrizoate Sodium
- Form
- SOLUTION
- Routes
- ORAL, RECTAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Diatrizoate Meglumine and Diatrizoate Sodium",
"splId": "2e7917f2-e573-cccb-e063-6294a90a203c",
"labels": [
{
"setId": "a216a7d5-3c28-482b-956a-93ae146e3763",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a216a7d5-3c28-482b-956a-93ae146e3763",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a216a7d5-3c28-482b-956a-93ae146e3763"
}
],
"routes": [
"ORAL",
"RECTAL"
],
"labeler": "Camber Pharmaceuticals, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "24 BOTTLE in 1 BOX (31722-019-31) / 30 mL in 1 BOTTLE (31722-019-30)",
"package_ndc": "31722-019-31",
"identifierStatus": "well-formed",
"marketing_start_date": "20231117"
},
{
"sample": false,
"description": "12 BOTTLE in 1 BOX (31722-019-32) / 120 mL in 1 BOTTLE (31722-019-12)",
"package_ndc": "31722-019-32",
"identifierStatus": "well-formed",
"marketing_start_date": "20231117"
}
],
"productId": "31722-019_2e7917f2-e573-cccb-e063-6294a90a203c",
"useDomain": "unknown",
"dosageForm": "SOLUTION",
"productNdc": "31722-019",
"deaSchedule": null,
"genericName": "Diatrizoate Meglumine and Diatrizoate Sodium",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "DIATRIZOATE MEGLUMINE",
"strength": "660 mg/mL"
},
{
"name": "DIATRIZOATE SODIUM",
"strength": "100 mg/mL"
}
],
"applicationNumber": "ANDA215049",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20231117",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0331722019125",
"0331722019309",
"0331722019316"
],
"unii": [
"3X9MR4N98U",
"V5403H8VG7"
],
"spl_set_id": [
"a216a7d5-3c28-482b-956a-93ae146e3763"
],
"manufacturer_name": [
"Camber Pharmaceuticals, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:31722-019_2e7917f2-e573-cccb-e063-6294a90a203c"